We also analyzed FABP4 and SREBP1 mRNA expression, which were linked to the expression of genes responsible for de novo hepatic lipogenesis, lipid storage, and nonalcoholic fatty liver disease pathogenesis [23,48]. This evidence concerns the gene FABP4 and metabolic dysfunction-associated steatotic liver disease.